Wave Life Sciences (WVE)

Wave Life Sciences (WVE) Financial Statements


Wave Life Sciences Financial Overview

Wave Life Sciences's market cap is currently ―. The company's EPS TTM is $-0.527; its P/E ratio is -10.66; Wave Life Sciences is scheduled to report earnings on August 1, 2024, and the estimated EPS forecast is $-0.21. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue$ 12.54M$ 29.06M$ 49.21M$ 22.11M$ 12.93M
Gross Profit$ 12.54M$ 29.06M$ 49.21M$ 22.11M$ 12.93M
EBIT$ -31.56M$ -16.26M$ 6.58M$ -21.10M$ -27.41M
EBITDA$ -29.38M$ -14.07M-$ -18.78M$ -24.97M
Net Income Common Stockholders$ -31.56M$ -16.26M$ 7.51M$ -21.10M$ -27.41M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 180.90M$ 200.40M$ 139.90M$ 173.00M$ 207.60M
Total Assets$ 235.27M$ 274.95M$ 199.92M$ 230.01M$ 267.27M
Total Debt$ 30.53M$ 32.12M$ 33.67M$ 35.16M$ 36.61M
Net Debt$ -150.37M$ -168.28M$ -106.23M$ -137.84M$ -170.99M
Total Liabilities$ 202.01M$ 227.44M$ 232.53M$ 281.70M$ 294.11M
Stockholders Equity$ 25.39M$ 39.63M$ -40.49M$ -51.72M$ -34.71M
Cash Flow-
Free Cash Flow$ -33.85M$ -33.59M-$ -37.33M$ 85.03M
Operating Cash Flow$ -33.43M$ -33.24M$ -34.46M$ -37.26M$ 85.52M
Investing Cash Flow$ -417.00K$ -356.00K$ -198.00K$ -72.00K$ -489.00K
Financing Cash Flow$ 14.51M$ 93.96M$ 1.67M$ 1.85M$ 35.05M
Currency in USD

Wave Life Sciences Earnings and Revenue History

Wave Life Sciences Debt to Assets

Wave Life Sciences Cash Flow

Wave Life Sciences Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis